clinical trial semaglutide New Wegovy finds surprising benefits that go way beyond weight loss The SELECT Trial - A

Wegovy-related adverse effects requiring assessment : Severe or persistent gastrointestinal symptoms : Whilst mild nausea is common initially, severe vomiting, inability to tolerate fluids, or signs of dehydration require medical review

Each vial contains 3000 mg of L-Carnitine, a molecule that transports fatty acids to the mitochondria for beta-oxidation, reducing adipose tissue and preserving muscle glycogen

both treatments decreased the size of atheroma plaques

Lipid-lowering medications that inhibit the activity of 3-hydroxy-3-methylglutaryl (HMG)-coenzyme A (CoA) reductase (statins), a critical enzyme in both cholesterol and coenzyme Q 10 biosynthesis, decrease plasma coenzyme Q 10 concentrations (see HMG-CoA reductase inhibitors [statins]), although it remains unproven that this has any clinical implications